Member Info for jmfw

Must be imminent. Probably no later than next week, may be sooner. Very exciting.

Not really surprising. Recent fund raisers (sng, odx,avct, gdr) all suffered similar fate. The sp has already delivered (nicely) for those who bought in below £1.50, & will recover (& beyond) to the heights recently achieved, it's just a matter of patience. Traders will have their moment as will those who hold for the mid/longer term.

Looks very promising. BBI, Rapid Test Consortium, CONDOR. Dovetail's pretty well in my view.

Sure your correct, but not understand why you think a sole investor took the shares. Great for us if that the case.

If of any interest, according to CNN
https://money.cnn.com/quote/shareholders/shareholders.html?symb=TLSA&subView=institutional

I read as a manouevre to invite sellers if there is no rns. On the other hand if there is news they are ahead of the game & start selling at higher prices.

Okyo is an embryonic tils, same management, structure, etc. Probably be a while for it to get to where we are, although probably one for the future. A long volatile journey ahead of it.

According to Investopedia
"The record date is the cut-off date used to determine which shareholders are entitled to a corporate dividend.
The record date will usually be the day following the ex-dividend date, which is the trading date on (and after) which the dividend is not owed to a new buyer of the stock.
To be eligible for the dividend, you must buy the stock at least two business days before the record date."

At moment showing as 18m+ against daily average 305k.
Even if US sp was $8.50, that wud equate to £3.20+. Onwards & upwards.

Think it just as well we're not keeping pace with US sp, cos it's got to be a spike. Traders will be very happy to jump on & off the train - some with big profits.

Think expectation been ramped up for some reason & I agree with comments/observations posted by Pigster & Timster earlier today. Can imagine the reaction from some contributors should avct not oblige.
When the (hoped for) outcome is communicated the problem faced will be supply to fill demand, as AS has alluded.

Not sure whether this already been covered. If our tech is being used for delivery & trial(s) succesful, surely an early 'earner', while substantiating the methodology. Any opinions?
https://www.clinicaltrialsarena.com/news/gilead-inhaled-remdesivir-phasei/
https://www.globenewswire.com/news-release/2020/06/29/2054456/0/en/Tiziana-Life-Sciences-Announces-Agreement-with-STC-Biologics-for-GMP-Manufacturing-of-an-anti-Interleukin-6-Receptor-Monoclonal

TLW, for info, this covered on TILS board under thread "Thoughts on OKYO Speculation" on 22 July. Majority view is that there will be no involvement between Tils & Okyo. My own view is that the Tils spin off (Stemprinter) will reverse into accuSTEM, which is a company set up by the management in June (I think).

My 2 penny worth. Okyo looks/reads like an embryonic Tils, just a different focus(ha ha), so unlikely. Someone previously mentioned AccuSTEM, which, to me, sounds exactly right.

Ophidian, thanks for repeating. Your appraisals always most informative.

Alansugar 13:51. Vol/Val Bought incongruous with sp. Notice o/a volume is 1.6m & not (653,156 + 488,675).

Detection via waste water sampling is already being explored & was the subject of a bbc item recently. The suggestion was/is that it is a very clear indicator of the presence of Covid significantly earlier than was apparent in the community. Think this potential development brilliant for avct. https://www.bbc.co.uk/news/science-environment-53257101

I agree & think we will sell Stem, but just wonder if it will be outright or with potential royalties (re rockz).
Also, think there is no likelihood TILS will be sold to big pharma at this stage as there are (effectively) so few shares currently circulating coupled with the fact that in excess of 75% are in the hands of only 4 holders (GC incl). If we take on trust/fact what yesterday's interview suggested, expectations, almost, cannot be measured.

Sure most of you know, but find this site most accurately reflects trading activity https://investing.thisismoney.co.uk/trades/TILS/Tiziana-Life-Sciences.html

In addition to obvious decriers there appear to be some 'sleepers' on here. I am optimistic for the short, medium, & long term. My only gripe is with myself in that I'm not savvy enough to play the drops. I find the best remedies for any dissatisfaction while waiting, is to filter, & only visit the board a couple of times a day (at least for the time being).
Avacta could be special, so happy to hold through thick & thin.